KING FAISAL SPECIALIST HOSPITAL AND RES CT has a total of 13 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are LIANG PENG, CANGENE CORP and AVEO PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Macromolecular chemistry and polymers | |
#6 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Khabar Khalid S Abu | 5 |
#2 | Al-Mohanna Futwan | 3 |
#3 | Al-Majhdi Fahad Nasser | 2 |
#4 | Parhar Ranjit | 2 |
#5 | Almousa Akram A | 2 |
#6 | Moftah Belal | 2 |
#7 | Khabar Khalid S A | 2 |
#8 | Basfar Ahmed Ali | 2 |
#9 | Abu Khabar Khalid S | 1 |
#10 | Kotwal Girish J | 1 |
Publication | Filing date | Title |
---|---|---|
US2014332693A1 | Method of using the novel polymer gel for magnetic resonance imaging (mri) validation | |
US2015050214A1 | Composition and method of making the novel 3d polymer gel for use in radiation treatment planning | |
EP2708234A1 | Tetraspanin CD82 as a diagnostic and/or therapeutic module for xenograft recognition and/or rejection | |
WO2012152295A1 | Pyrazolyl compounds for use in reversing reactive gliosis | |
WO2012143020A1 | Multiple interferon and virus response element cell-based fluorescence system | |
EP2603589A1 | Fluorescent proteins with increased activity in cells | |
EP2382319A1 | A method for increasing protein expression in cells | |
CA2374681A1 | Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection |